EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

Syed Waqas Ali Shah, Xingxing Li, Hao Yuan, Huiling Shen, Shaohao Quan, Guifang Pan, Muhammad Ishfaq, Abid Ullah Shah, Hanhan Xie, Jundong Shao

BMEMat · 2025-12 · 3 (4)

DOI: 10.1002/bmm2.70001 ↗
AbstractBibliografische Angaben

Abstract

Abstract Recent strides in non‐invasive drug delivery have spurred innovation in alternatives to traditional needle injections. Transdermal drug delivery systems (TDDs) have emerged as a particularly promising avenue, boasting minimal rejection rates, user‐friendly administration, and enhanced patient adherence. Beyond pharmaceuticals, TDDs show potential in skincare and cosmetics, leveraging their ability to facilitate localized drug delivery while minimizing systemic exposure. Nonetheless, the intricate physicochemical nature of the skin presents formidable obstacles, prompting intensive exploration to overcome these barriers. This comprehensive review delves into the landscape of TDDs methodologies, critically analyzing their respective advantages, limitations, characterization methodologies, and prospective applications. Recent advancements underscore the robust efficacy of TDDs, positioning it as a versatile and indispensable modality poised for widespread integration across multifarious fields.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →